Robinson, 1940 - Google Patents
Presidential address. A. Some aspects of the chemotherapy of tuberculosisRobinson, 1940
- Document ID
- 18321456489647124939
- Author
- Robinson R
- Publication year
- Publication venue
- Journal of the Chemical Society (Resumed)
External Links
Snippet
were relatively inactive and the best results were usually obtained with acids containing 16 or 17 carbon atoms. The effect of constitution is shown well in the n-pentadecanecarboxylic acids. Here palmitic acid is inactive, but a-methylpentadecoic acid is leprocidal in a dilution …
- 201000008827 tuberculosis 0 title description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/937—Dispersion or emulsion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Micro-organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3551554A (en) | Enhancing tissue penetration of physiologically active agents with dmso | |
| US5646181A (en) | Method and compositions for treating impotence | |
| US4411893A (en) | Topical medicament preparations | |
| KR950008766B1 (en) | Skin Permeable Composition | |
| DE60026826T2 (en) | AGING PROTECTION TAPE, THIS PHARMACEUTICAL COMPOSITION, AND ITS USE | |
| US3809714A (en) | Novel ester of ((methylamino)methyl) benzyl alcohol | |
| US6056966A (en) | Method and compositions for treating impotence | |
| JP3682721B2 (en) | Benzopyranphenol derivatives for use as antibacterial, antiviral or immunostimulants | |
| Harrell et al. | North American blastomycosis | |
| JPH0725680B2 (en) | Topical drug composition | |
| EP0055029B1 (en) | Preparations for the treatment of dermatoses | |
| DE3115383A1 (en) | ANTI-ALLERGIC AGENT | |
| US5258391A (en) | Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use | |
| UA76415C2 (en) | Use of biguanide derivatives for making medicine having wound healing effect | |
| JPH01143832A (en) | Carcinostatic agent | |
| Robinson | Presidential address. A. Some aspects of the chemotherapy of tuberculosis | |
| EP0038567B1 (en) | Deazapurine nucleoside, formulations thereof, and use thereof in therapy | |
| WELSH | LUPUS ERYTHEMATOSUS: Treatment by Combined Use of Massive Amounts of Panthothenic Acid and Vitamin E | |
| US4895872A (en) | Immunosupressive analogues and derivatives of succinylacetone | |
| DE2411823A1 (en) | USE OF 1,2,4-TRIAZOL-3-CARBOXAMIDES AND THIOCARBOXAMIDES AS ANTIVIRUS AGENTS | |
| Perla et al. | A substance in urine of normal human adults that raises the resistance of suprarenalectomized rats. | |
| Gross et al. | Hepatic lipidosis associated with L-asparaginase treatment | |
| JPH06239757A (en) | Antiallergic agent | |
| GROLLMAN | The preparation of extracts from oxidized marine and other oils for reducing the blood pressure in experimental and human chronic hypertension | |
| JPH0368516A (en) | Na↑+, K↑+-ATPase inhibitor |